Table 4.
PFS (n=195**) |
OS* (n=195**) |
||||||
---|---|---|---|---|---|---|---|
| |||||||
Factor |
p-value | Hazard Ratio |
95% CI on Hazard Ratio |
Factor | p-value | Hazard Ratio |
95% CI on Hazard Ratio |
| |||||||
MYCN amplification | <0.0001 | 3.4 | (2.2, 5.3) | MYCN amplification | 0.001 | 2.0 | (1.3, 2.9) |
11q LOH | 0.02 | 2.6 | (1.2, 5.9) | 11q LOH | 0.01 | 2.8 | (1.3, 6.3) |
11q unknown | 0.7 | 0.9 | (0.5, 1.6) | 11q unknown | 0.6 | 1.2 | (0.6, 2.1) |
CI = confidence interval
“Era” was tested in the OS model but was not statistically significant.
Patients for whom both factors were unknown were excluded.